Simba Gill - Net Worth and Insider Trading
Simba Gill Net Worth
The estimated net worth of Simba Gill is at least $9 dollars as of 2024-05-25. Simba Gill is the President & CEO of Evelo Biosciences Inc and owns about 17,758 shares of Evelo Biosciences Inc (EVLO) stock worth over $9. Details can be seen in Simba Gill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Simba Gill has not made any transactions after 2023-11-08 and currently still holds the listed stock(s).
Transaction Summary of Simba Gill
Simba Gill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Simba Gill owns 2 companies in total, including Foghorn Therapeutics Inc (FHTX) , and Evelo Biosciences Inc (EVLO) .
Click here to see the complete history of Simba Gill’s form 4 insider trades.
Insider Ownership Summary of Simba Gill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2020-10-22 | director |
| EVLO | Evelo Biosciences Inc | 2023-11-08 | director & President & CEO |
Simba Gill Latest Holdings Summary
Simba Gill currently owns a total of 1 stock. Simba Gill owns 17,758 shares of Evelo Biosciences Inc (EVLO) as of November 8, 2023, with a value of $9.
Latest Holdings of Simba Gill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EVLO | Evelo Biosciences Inc | 2023-11-08 | 17,758 | 0.00 | 9 |
Holding Weightings of Simba Gill
Simba Gill Form 4 Trading Tracker
According to the SEC Form 4 filings, Simba Gill has made a total of 4 transactions in Evelo Biosciences Inc (EVLO) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Evelo Biosciences Inc is the sale of 172 shares on November 8, 2023, which brought Simba Gill around $57.
Insider Trading History of Simba Gill
- 1
Simba Gill Trading Performance
Simba Gill Ownership Network
Simba Gill Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Simba Gill is the director of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief Strategy/Bus Ops Officer Fanny Cavalie , Chief Medical Officer Alfonso Quintas Cardama , and Chief Medical Officer Samuel Agresta .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Simba Gill made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , and a net sale of 11,000 shares made by Fanny Cavalie .
In summary, during the past 3 months, insiders sold 11,000 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 11,000 shares. During the past 18 months, 322,297 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,297 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Simba Gill Mailing Address
Above is the net worth, insider trading, and ownership report for Simba Gill. You might contact Simba Gill via mailing address: 515 Galveston Dr, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
